0.57
0.57 (0%)
As of Jun 06, 2024
Thermogenesis Holdings, Inc. [THMO]
Source:
Company Overview
Thermogenesis Holdings, Inc develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. Since the 1990’s ThermoGenesis Holdings has been a pioneer in, and a leading provider of automated systems that isolate, purify and cryogenically store units of hematopoietic stem and progenitor cells for the cord blood banking industry.
| Country | United States |
| Headquarters | rancho cordova, california |
| Phone Number | 9168585100 |
| Industry | manufacturing |
| CEO | Chris Xu |
| Website | www.thermogenesis.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $0 |
| Net Income | $0 |
| Net Cash | $-0.8 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | 184.1% |
| Return on Assets | -19.8% |
| Turnover Ratio | |
| EBITA |
Balance Sheet and Cash Flow Measures
| Total Assets | $10.1 |
| Total Liabilities | $11.2 |
| Operating Cash Flow | $-0.5 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $-0.3 |
